Eliem Therapeutics (ELYM) Stock Chart & Stock Price History $2.23 0.00 (0.00%) As of 09/2/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Eliem Therapeutics Stock Price Performance The Eliem Therapeutics (ELYM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 67.35%, with a year-to-date return of 20.54%. In the past month, the stock has increased 47.68%, reflecting recent market activity. As of the latest close, Eliem Therapeutics traded at $2.23 with a market cap of $66.35 million and volume of 288,906 shares. Receive ELYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-3.04%1 Month Performance+47.68%3 Month Performance+88.98%Year-To-Date Performance+20.54%1 Year Performance-67.35% ELYM Stock Chart for Wednesday, September, 3, 2025 ELYM Chart by TradingView Eliem Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/03/2025$2.23$2.23$2.26$2.12323,223 shs$66.35 million09/02/2025$2.23$2.23$2.38$2.22288,906 shs$66.35 million09/01/2025$2.23$2.23$2.38$2.22288,906 shs$66.35 million08/29/2025$2.29$2.30+0.66%$2.38$2.28244,073 shs$68.43 million08/28/2025$2.48$2.29-7.86%$2.41$2.20620,138 shs$67.98 million08/27/2025$2.48$2.48$2.52$2.351.05 million shs$73.79 million08/26/2025$2.38$2.48+4.20%$2.52$2.351.05 million shs$73.79 million08/25/2025$2.38$2.38$2.42$2.17803,871 shs$70.81 million08/22/2025$2.25$2.19-2.67%$2.28$2.14645,753 shs$65.16 million08/21/2025$2.02$2.25+11.39%$2.29$1.98878,696 shs$66.94 million Get the Latest News and Ratings for ELYM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/20/2025$2.11$2.02-4.27%$2.26$2.01837,446 shs$60.10 million08/19/2025$1.90$2.11+11.05%$2.15$1.931.66 million shs$62.78 million08/18/2025$1.90$1.90$1.93$1.731.15 million shs$56.53 million08/15/2025$1.63$1.72+5.52%$1.72$1.61404,398 shs$51.17 million08/14/2025$1.61$1.63+1.24%$1.69$1.60384,840 shs$48.50 million08/13/2025$1.65$1.61-2.42%$1.68$1.55492,154 shs$47.90 million08/12/2025$1.70$1.65-2.94%$1.72$1.64370,703 shs$49.09 million08/11/2025$1.70$1.70$1.75$1.66260,942 shs$50.58 million08/08/2025$1.70$1.70$1.78$1.664.70 million shs$50.58 million08/07/2025$1.70$1.70$1.78$1.664.70 million shs$50.58 million08/06/2025$1.70$1.70$1.78$1.664.70 million shs$50.58 million08/05/2025$1.45$1.70+17.24%$1.78$1.664.70 million shs$50.58 million08/04/2025$1.45$1.45$1.46$1.36145,775 shs$43.14 million Related Companies Aurora Cannabis Stock Price Chart scPharmaceuticals Stock Price Chart Monte Rosa Therapeutics Stock Price Chart Atea Pharmaceuticals Stock Price Chart Neurogene Stock Price Chart Cartesian Therapeutics Stock Price Chart Neumora Therapeutics Stock Price Chart Mereo BioPharma Group Stock Price Chart Lifecore Biomedical Stock Price Chart Tvardi Therapeutics Stock Price Chart Receive ELYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELYM) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eliem Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELYM Stock Alerts